The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland: a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone Metastases

To estimate the total number of skeletal-related events (SREs), the associated hospital burden and direct medical costs when denosumab is used instead of zoledronic acid in patients with prostate cancer (PC) and bone metastases (BMs).

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: J Cristino, J Finek, N Maniadakis, M Perez Encinas, R Ikenberg, I Campos Tapias, P Jandova, DP Zahn, C Moser, L Bolognese, G Tritaki, F Gatta, G Hechmati Source Type: research